These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 12520711)

  • 21. Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy: a follow-up study on 309 patients.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Diehl V
    Leuk Lymphoma; 2003 Jun; 44(6):949-53. PubMed ID: 12854892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the volume ratio of bone marrow affected by fibrosis: a parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemia.
    Buesche G; Georgii A; Duensing A; Schmeil A; Schlue J; Kreipe HH
    Hum Pathol; 2003 Apr; 34(4):391-401. PubMed ID: 12733122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Onset of polycythemia in idiopathic myelofibrosis. Description of a clinical case and review of the literature].
    Pagano L; Teofili L; Marra R; Storti S; Rabbitti C; Leone G; Bizzi B
    Minerva Med; 1988 Jan; 79(1):51-4. PubMed ID: 3277085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow histopathology in myeloproliferative disorders--current diagnostic approach.
    Thiele J; Kvasnicka HM; Orazi A
    Semin Hematol; 2005 Oct; 42(4):184-95. PubMed ID: 16210032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple myeloma with bone marrow biopsy features simulating concomitant chronic idiopathic myelofibrosis.
    Schmidt U; Ruwe M; Leder LD
    Nouv Rev Fr Hematol (1978); 1995; 37(2):159-63. PubMed ID: 7644355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies.
    Buesche G; Georgii A; Kreipe HH
    Histopathology; 2006 Jan; 48(2):133-48. PubMed ID: 16405662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idiopathic myelofibrosis.
    Barosi G; Hoffman R
    Semin Hematol; 2005 Oct; 42(4):248-58. PubMed ID: 16210038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow histopathology following cytoreductive therapy in chronic idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Diehl V
    Histopathology; 2003 Nov; 43(5):470-9. PubMed ID: 14636273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): a retrospective clinicopathological study of 120 patients.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Zankovich R; Diehl V
    Am J Hematol; 2002 Aug; 70(4):283-91. PubMed ID: 12210809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Choice of therapy and overall survival in patients with chronic myeloproliferative diseases].
    Rukavitsyn OA; Pop VP; Seriakov AP
    Vopr Onkol; 2004; 50(4):435-9. PubMed ID: 15605767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Coincidence of chronic idiopathic myelofibrosis and chronic lymphocytic leukaemia. A rare phenomenon?].
    Böhm J; Schaefer HE; Fisch P
    Pathologe; 2002 Nov; 23(6):480-5. PubMed ID: 12436302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quantitative study of the medullar fibrosis in 84 cases of idiopathic myeloid splenomegaly (author's transl)].
    Dumont J; d'Athis P; Atken N; Binet JL; Ripault J; Worhauer W; Bernard J
    Pathol Biol (Paris); 1979 Apr; 27(4):221-6. PubMed ID: 379761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome.
    Pullarkat V; Bass RD; Gong JZ; Feinstein DI; Brynes RK
    Am J Hematol; 2003 Jan; 72(1):8-12. PubMed ID: 12508261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis.
    Hasselbalch H; Lisse I
    Eur J Haematol; 1991 May; 46(5):285-9. PubMed ID: 2044723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The beneficial effect of 1,25-dihydroxycholecalciferol on the excess of blasts and the myelofibrosis in 2 cases of chronic myeloproliferative syndrome].
    Raya Sánchez JM; Hernández Nieto L; Brito Barroso ML; Hernández García MT
    Med Clin (Barc); 1994 Mar; 102(10):380-2. PubMed ID: 8182985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remission of chronic idiopathic myelofibrosis to busulfan treatment.
    Chang JC; Gross HM
    Am J Med Sci; 1988 May; 295(5):472-6. PubMed ID: 3376991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in the therapy of chronic idiopathic myelofibrosis.
    Arana-Yi C; Quintás-Cardama A; Giles F; Thomas D; Carrasco-Yalan A; Cortes J; Kantarjian H; Verstovsek S
    Oncologist; 2006 Sep; 11(8):929-43. PubMed ID: 16951397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus.
    Paquette RL; Meshkinpour A; Rosen PJ
    Medicine (Baltimore); 1994 May; 73(3):145-52. PubMed ID: 8190037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive myelofibrosis responsive to treatment for acute erythroblastic leukaemia.
    Fadilah SA; Raja-Zahratul-Azma RS; Leong CF
    Malays J Pathol; 2006 Jun; 28(1):55-8. PubMed ID: 17694960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.